NCT01437319View on ClinicalTrials.gov

Mucin Balls and Corneal Inflammation Events

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Corneal InflammationCorneal Infiltrative Events
Interventions
DEVICE

lotrafilcon A

To be used during run-in phase only.

DEVICE

comfilcon A

To be assigned at randomization at phase 2 only.

DEVICE

balafilcon A

To be assigned at randomization during phase 2 only.

OTHER

etafilcon A

Assigned to Neophytes during Phase I for a 2-week period

Trial Locations (3)

Unknown

Beachwood

Cleveland

Columbus

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT01437319 - Mucin Balls and Corneal Inflammation Events | Biotech Hunter | Biotech Hunter